Back to search
Relative Bioavailability
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Relative Bioavailability trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Relative Bioavailability trials you may qualify forThe purpose of this study is to evaluate the relative bioavailability (rBA) of the Form 2 film-coated tablet of PF-07799933 intended for use in future studies c…
This study is a randomized, parallel, open-label Phase I clinical trial aimed at comparing the bioavailability and safety of different specifications of SHR-316…
Healthy adults will be enrolled into this open-label, Phase 1 research study. Participants will spend about 9 nights and 10 days in the clinical research unit (…
The purpose of this study is to assess how well laroprovstat and rosuvastatin combined in a single tablet to be taken by mouth works compared with laroprovstat…
The goal of this clinical trial is to assess the safety and effects of a crystallized form of lithium, AL001, when compared to commonly used lithium carbonate i…
The main objective of this trial is to evaluate the pharmacokinetics of two evolocumab drug products in healthy participants.
The purpose of this study is to determine the relative bioavailability (rBA; Period 1) and bioequivalence (BE; Period 2 and 3) of various strengths and formulat…
This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of AZD6234. This study will take…